Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new suicide prevention app called MAPS. The app is designed to be personalized and to help people who are struggling with suicidal thoughts. The trial will test the feasibility, acceptability, and safety of the app, and establish key parameters for its effectiveness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 70 years old.I have had thoughts or actions related to suicide in the last month.I have had thoughts or actions of suicide in the last month.I am between 18 and 70 years old.I have had thoughts or actions of suicide in the last month.You are able to read, write, and understand English well enough to complete study procedures.You have a smartphone.
- Group 1: EMA Monitoring Only (EMO)
- Group 2: Mobile Application to Prevent Suicide (MAPS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is my profile compatible with the requirements for this medical research project?
"Candidates are eligible for this research if they have a history of suicidal ideation and are aged between 18-70. This trial is hoping to recruit approximately 50 individuals in total."
Does this trial admit geriatric patients?
"This research study only accepts subjects aged between 18 and 70. Those younger than 18 can partake in 83 different trials, while those over 65 may join 152 different studies."
Do you still have openings for participants in this trial?
"Clinicaltrials.gov reports that, at present, this trial is not accepting new patients. The initial posting was made on October 1st 2022 and the latest update to the listing occurred on August 19th of the same year. Although recruitment for this specific study has been suspended, there are 240 other trials actively searching for applicants presently."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger